Kobo Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, revenue was INR 0.166 million compared to INR 0.359 million a year ago. Net loss was INR 48.09 million compared to INR 170.43 million a year ago. Basic loss per share from continuing operations was INR 2.02 compared to INR 7.15 a year ago.